title: Guidelines for the management of chronic hepatitis C in patients infected after substance use.
authors.affiliation: Department of Gastroenterology and Hepatology, Ziekenhuis Oost Limburg, Genk, Schiepse Bos, 6, B-3600 Genk, Belgium. geert.robaeys@zol.be
authors.forename: G
authors.initials: G
authors.lastname: Robaeys
authors.forename: F
authors.initials: F
authors.lastname: Buntinx
authors.forename: E
authors.initials: E
authors.lastname: Bottieau
authors.forename: S
authors.initials: S
authors.lastname: Bourgeois
authors.forename: R
authors.initials: R
authors.lastname: Brenard
authors.forename: I
authors.initials: I
authors.lastname: Colle
authors.forename: J
authors.initials: J
authors.lastname: De Bie
authors.forename: C
authors.initials: C
authors.lastname: Matheï
authors.forename: J P
authors.initials: JP
authors.lastname: Mulkay
authors.forename: P
authors.initials: P
authors.lastname: Van Damme
authors.forename: M
authors.initials: M
authors.lastname: Van Ranst
authors.forename: R
authors.initials: R
authors.lastname: Verrando
authors.forename: P
authors.initials: P
authors.lastname: Michielsen
authors.forename: N
authors.initials: N
authors.lastname: Bourgeois
authors.forename: R
authors.initials: R
authors.lastname: Brenard
authors.forename: Ch
authors.initials: Ch
authors.lastname: de Galocsy
authors.forename: J
authors.initials: J
authors.lastname: Delwaide
authors.forename: J
authors.initials: J
authors.lastname: Henrion
authors.forename: Y
authors.initials: Y
authors.lastname: Horsmans
authors.forename: P
authors.initials: P
authors.lastname: Michielsen
authors.forename: H
authors.initials: H
authors.lastname: Reynaert
authors.forename: G
authors.initials: G
authors.lastname: Robaeys
authors.forename: D
authors.initials: D
authors.lastname: Sprengers
mesh_terms: D000931:Antidotes / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D001530:Belgium / Q000453:epidemiology; D003131:Combined Modality Therapy; D015897:Comorbidity; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D008297:Male; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000931:Antidotes; D000998:Antiviral Agents